mist: parp inhibitors for malignant mesothelioma
Published 3 years ago • 93 plays • Length 2:39Download video MP4
Download video MP3
Similar videos
-
8:21
mist: personalized approaches to mesothelioma treatment
-
1:31
mist: molecularly targeted therapy for malignant pleural mesothelioma
-
3:34
mist5: niraparib and dostarlimab in relapsed malignant mesothelioma
-
1:33
exciting randomized trials for mesothelioma: checkpoint inhibitor monotherapies and vinorelbine
-
3:12
parp-inhibitors: a new generation of cancer drugs
-
2:28
a morphomolecular classification of malignant pleural mesothelioma
-
2:52
advances in mesothelioma treatment
-
1:54
abemaciclib in patients with p16ink4a negative, relapsed mesothelioma
-
1:13
mesothelioma biology: key genes and therapeutic targeting
-
18:08
new treatment avenues in malignant mesothelioma
-
3:01
the role of piez01 variants in patients with mds
-
5:53
priothera
-
8:56
the safe and effective use of bis™, pt.3: bis™ monitoring
-
12:33
pattern 5 – nodules, malignant mesothelioma (top 25 pearls series, topic 5, pearl 1)
-
1:10
the role of hipec in peritoneal mesothelioma, gi and ovarian cancers
-
34:46
the role of surgery in malignant pleural mesothelioma - harvey pass, md
-
13:57
malignant mesothelioma
-
1:15
pacritinib – is it safe for treating mf?